Purpose: To formulate carbomer gel to localize and target drug action in periodontal pockets. Methods: Diclofenac sodium (DS, anti-inflammatory) 
INTRODUCTION
Periodontitis is an inflammatory disease caused by chronic bacterial infection of the gum and bone supporting the teeth [1, 2] . Antimicrobial agents such as metronidazole, tetracycline and erythromycin are used to treat bacterial infections in periodontal diseases [3] . Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and diclofenac sodium are used to treat pain and inflammation. These drugs are administered locally as gel or given orally in the form of tablets. Due to their short half life, these medications have to be taken frequently to maintain the desired therapeutic effect.
In periodontal diseases, both drugs are used simultaneously to treat infection and inflammation. A single delivery system which can deliver both drugs is expected to be more convenient, beneficial and improve patient compliance.
Hence in the present investigation, we have attempted to develop a gel formulation loaded with diclofenac sodium and metronidazole. Since the preparation has the same base at the time of administration, gel containing diclofenac sodium and metronidazole can be simply mixed and applied to the periodontal cavity with a special dispenser [4] used by the periodontist to deliver medication or gel formulation into periodontal pockets.
Though microspheres loaded with antimicrobials have been reported and are currently available in the market [5] , none includes microspheres loaded with both an anti-inflammatory and antimicrobial drugs. Sustained release formulations will be beneficial to patients with gastric ulceration or sensitivity to the drug, as the drug effect would be localized. Administration of the conventional drug delivery systems of metronidazole leads to side effects such as nausea and vomiting [6] .
Carbomer (carboxy vinyl polymer) is a very high molecular weight polymer of acrylic acid with cross linkages of allyl sucrose [7] . Due to the high proportion of the carboxy groups present, carbomer solution is known to be acidic. It is also of low viscosity but when neutralized with triethanolamine, it is converted to highly viscous gels. The adhesive prosperities of carbomer are exploited to develop bioadhesive gels and drug delivery systems for controlled and localized drug delivery [8] [9] [10] . .
To obtain a sustained and targeted delivery, drugs can encapsulated in gelatin microspheres, which are then formulated as a gel using carbomer. To overcome problems associated with the conventional system, we aimed to develop a bioadhesive gel formulation which can sustain and localize the drug in the periodontal pockets for an effective treatment.
EXPERIMENTAL Materials
Gelatin (type B, 300 bloom strength) was purchased from Sigma Chemicals, USA. Carbopol 934 and triethanolamine GR (99 % purity) were purchased from Loba Chemie, India. Metronidazole hydrochloride and diclofenac sodium were gifts from Arvind Remedies, Thiruvellore, Chennai, India. Glutaraldehyde and isopropyl alcohol were obtained from S.D. Fine Chemicals Ltd., Mumbai, India. Span 80, Tween 80, acetone and toluene were purchased from Indian Research Products, Chennai, India.
Preparation of gelatin microspheres
Three grams of gelatin were accurately weighed and mixed in 10 ml of distilled water; preheated to 60 ºC, followed by the addition of Tween 80 (0.1 %w/v). To this, 1 g of diclofenac sodium was added and thoroughly mixed to obtain a homogeneous solution. The mixture was maintained at 50 C, and then added drop wise into 100 ml of sesame oil containing Span 80 (0.1 %w/v) preheated to 60 C while stirring at 1000 rpm with a 3-blade stirrer (Remi, India) in order to form a w/o emulsion. Toluene (0.5 ml) saturated with glutaraldehyde was added drop-wise to the emulsion and stirring and stirred for 1 h at room temperature to stabilize the microspheres. The mixture was then left to cool at between 5 -10 °C for 30 min to enhance settling of the microspheres. The microspheres were collected by filtration using Whatman filter paper (no. 41) and washed with 3 x 10 ml of chloroform followed by 2 x 10 ml of 5 %w/v sodium metabisulphite. Finally, the microspheres were washed with 10 ml of acetone, dried at room temperature and transferred to glass vials that were stored in desiccators until used. Similarly, microspheres loaded with metronidazole and unloaded microspheres were formulated and stored in desiccators.
Preparation of gel
Preparation of the carbomer gel was based on a previously reported composition and method [7] . Accurately weighed diclofenac sodium (100 mg) was added to 15 ml of water in a beaker and stirred well to dissolve the drug; 400 mg of carbopol was dissolved in this drug solution. Gelatin microspheres loaded with 100 mg of diclofenac sodium was added to the drug-carbopol solution and mixed well. Methyl hydroxybenzoate (0.15 %w/w), propyl hydroxybenzoate (0.05 %w/w) and sodium metabisulphate (0.1 %w/w)) were then added to microsphere/drug/carbopol mixture, while stirring at 250 rpm, to obtain a homogenous mixture. Stirring was continued until a lump-free suspension was obtained. Thereafter, 0.33 ml of triethanolamine was added to produce a gel. This was followed by the addition of a sweetening agent (saccharin sodium, 0.1 %w/w) and more water to make up to 20 g of gel. Similarly, a gel containing metronidazole hydrochloride was prepared. The amount of metronidazole used was the same as that of diclofenac.
Determination of drug content
The amount of diclofenac sodium presents in the gelatin microspheres was determined by digestion with 1M sodium hydroxide [11] .
Briefly, 100 mg of microspheres was dispersed in 100 ml of 1M sodium hydroxide in a 100 ml standard flask. and kept overnight for 12 h. It was then filtered, diluted and diclofenac sodium content was determined spectrophotometrically (Shimadzu 1601) at 276 nm. Sodium hydroxide (M) was used as blank. The amount of metronidazole present in gelatin microspheres was determined by digestion with hydrochloric acid [12] . Briefly, 100 mg of microspheres was dispersed in 100 ml of 1M hydrochloric acid in a 100 ml standard flask and kept overnight for 12 h. It was then filtered, diluted and metronidazole hydrochloride content was determined at 320 nm. Hydrochloric acid (1M) was used as blank. .
Determination of percentage of drug loading
The percentage of diclofenac sodium and metronidazole hydrochloride loading in microspheres can be estimated using Eq 1.
where, L is the loading (%) of microspheres, Q m is the quantity of diclofenac sodium and metronidazole hydrochloride present in W m of microspheres and W m is the weight of the microspheres in grams
Determination of encapsulation efficiency
The amount of diclofenac sodium and metronidazole hydrochloride encapsulated in the microspheres was determined using Eq 2.
……………………….. (2) where E is encapsulation efficiency (%), The microspheres were analyzed for size and size distribution by first dispersing them in 20 % v/v isopropyl alcohol to avoid swelling, vortexing for 3 min and ultrasonicating for 30 s before sampling. The particle size was measured by laser diffraction (Shimadzu Sald 1100, Japan) and plotted for size distribution using the software supplied by the manufacturer.
Scanning electron microscopy
The sample the scanning electron microscopy (SEM) analysis was prepared by sprinkling the microspheres on one side of the double adhesive stub. The stub was then coated with gold using Jeol JFC 1100 sputter coater.
The SEM analysis of the microspheres was carried out using Jeol JSM 5300, Japan. The microspheres were viewed at an accelerating voltage of 15-20 kV.
Differential scanning calorimetry
Differential scanning calorimetry (DSC) of diclofenac sodium, metronidazole hydrochloride and microspheres were performed using Perkin-Elmer DSC7 model. The instrument was calibrated with indium. All the samples (5 mg) were heated in sealed aluminum pans with perforated lids using dry nitrogen as the effluent gas. The analysis was performed in the temperature range of 50 -400 °C and at a rate of 20°C min -1 .
Evaluation of in vitro release by static method
Microspheres, equivalent to 10 mg of diclofenac sodium, were accurately weighed and transferred to 250 ml conical flask containing 100 ml phosphate buffer (pH 7.2). The flask was kept in an incubator at 37 C, 1 ml samples withdrawn at regular intervals and, after suitable dilution, the amount of drug released was determined using a spectrophotometer at 276 nm. Following each sample withdrawal, 1 ml of phosphate buffer was added to the release medium to replenish it. Five minutes before each sampling, the flasks were gently shaken by manually whirling it clockwise (15 revolutions) to minimize any concentration gradient within the release medium. The microspheres were allowed to settle down and clear supernatant medium withdrawn for drug analysis. The sample was filtered and the microspheres collected were transferred to the dissolution flask. Similarly, the release of metronidazole hydrochloride from gelatin microspheres was determined spectrophotometrically at 320 nm (Shimadzu 1601).
Evaluation of in vitro release by dynamic method
Evaluation in vitro release studies of diclofenac sodium or metronidazole hydrochloride from the carbomer gel was carried out at 37 C using phosphate buffer (pH 7.2) as the release medium. A glass tube of 10 mm diameter and 100 mm height was taken. One end of the tube was closed using an egg membrane with the help of adhesive tape while the other end was kept open and used as drug reservoir compartment. Gel (1 g) containing diclofenac sodium was accurately weighed and transferred to the glass tube in a vertical position through the open end. The gel was gently pushed down to the surface of the egg membrane with the help of a stainless steel spatula to ensure that all the gel was in contact with the membrane. Phosphate buffer (2 ml, pH 7.2) was added to the reservoir compartment to wet the gel. The glass tube was placed in a beaker containing 100 ml of phosphate buffer (pH 7.2) such that that the egg membrane is just immersed in the phosphate buffer which acted as the receiving compartment. The receiving compartment was magnetically stirred (100 rpm, Remi, India) at 37 C. Samples (1 ml) were withdrawn from the receiving compartment at regular intervals and the amount of diclofenac sodium released from the gel was determined using a spectrophotometer at 276 nm (Shimadzu 1601). After each withdrawal of sample, an equal quantity of phosphate buffer was added to the receiving compartment to replenish it. Similarly metronidazole hydrochloride release from the gel was determined spectrophotometrically at 320 nm.
Release kinetics
Data obtained from in vitro release studies were fitted to various kinetic equations [11] to determine the mechanism of drug release from the microspheres. The kinetic models used were zero order equation, first order equation and Higuchi release using the following plots: Q t vs t, log (Q 0 -Q t ) vs t and Q t vs square root of t, respectively; where Q t is the amount of drug released at time t and Q 0 is the initial amount of drug present in the microspheres. T further, to ascertain the mechanism of drug release, the first 60 % of drug release was fitted to Korsmeyer-Peppas model (Eq 3).
where M t /M  is the fraction of drug released at time, t, k is the rate constant and n is the release exponent. The n value is used to characterize different release mechanisms.
Statistical analysis
Drug loading, entrapment and encapsulation efficiency data were analyzed by one sample T-test while drug release data were analyzed by two-way ANOVA. PASW 18 statistics software (IBM, USA) was used for statistical analysis and confidence level was set at p < 0.05.
RESULTS

Drug loading, entrapment and encapsulation efficiency
The loading, entrapment and encapsulation efficiencies of the microspheres were 23.4, 93.6 and 74.9 %, respectively, for diclofenac and 21.5, 86.0 and 73.1 %, respectively, for metronidazole. There was no significant difference (p > 0.05) between two drugs with regard to these parameters.
Particle size of microspheres
The size distribution profiles of the microspheres are shown in Figure 1 . The particle size of unloaded microspheres ranged from 1 -50 m compared with 10-110 m for the drug-loaded microspheres. Mean diameter of unloaded, diclofenac sodium-loaded and metronidazole hydrochloride-loaded microspheres was 33.5, 67.8 and 51.4 m, respectively. 
Scanning electron microscopy
The microspheres exhibited good spherical geometry as evident by the SEM photomicrographs in Figure 2 . However, diclofenac sodium microspheres were larger size and showed less aggregation than metronidazole microspheres.
Differential scanning calorimetry
The thermogram of unloaded microspheres showed no peaks while the thermogram of diclofenac sodium showed a sharp peak at its melting point (276 ºC). The physical mixture of unloaded microspheres and diclofenac sodium showed a less prominent peak at 276 ºC but the peak was absent in diclofenac sodium-loaded microspheres (Figure 3 ). Similarly, the thermogram of metronidazole hydrochloride showed a sharp peak at its melting point of 160 ºC while the physical mixture of unloaded microspheres and metronidazole hydrochloride showed a less prominent at 160 ºC and the peak was absent in metronidazole-loaded microspheres. 
In vitro drug release
The cumulative release of diclofenac sodium and metronidazole from microspheres and gels are shown in Figure 5 . Drug from the microspheres was released in a controlled manner for > 4 h. The release pattern was biphasic with an initial 'burst' release of 34 % of the loaded drug was in the first 10 min. Thereafter, release was slow but steady, and by the end of the 4 th hour, 85 % of the loaded drug was released.
Diclofenac release from the carbomer gel formulation is also shown in Figure 5 . The release pattern was biphasic with an initial 'burst' release that was enhanced by the loading dose of diclofenac sodium. By the end of the first 10 min, 45 to 48 % of the drug was released; subsequently, release was steady and by the end of the 4 th h, 90 % of the drug was released. The data for the microsphere and gel containing metronidazole are similar with slow drug release that reached a plateau in 3 -4 h. There was significant difference (p < 0.05) between the release rates of diclofenac sodium and metronidazole from microspheres with the former greater. A similar difference between the two drugs was observed with regard to the formulated gels.
Release kinetics
Drug release from the microspheres followed more closely the Higuchi model with a regression coefficient (r 2 ) of 0.9793 compared with first order ((r 2 = 0.9522) and zero order models (r 2 = 0.8289). Subjection of the release data to Korsmeyer-Peppas analysis yielded n value of 0.37 for diclofenac sodium and 0.38 for metronidazole hydrochloride.
DISCUSSION
Sesame oil containing 0.1 %v/v Span 80 as dispersing medium produced drug-loaded gelatin microspheres with good loading and spherical geometry. The addition of surfactant contributed to the good spherical geometry and reduced aggregation of the microspheres. Diclofenac sodium was better encapsulated in gelatin microspheres than the metronidazole and this could be attributed to the high protein binding nature of diclofenac sodium [6] .
The microspheres were incorporated in a conventional carbomer gel formulation [7] . Carbopol 934 is a commercial grade of carbomer. It is gelled by neutralization with triethanolamine. Methyl hydroxylbenzoate and propyl hydroxylbenzoate are used as antimicrobial preservative; while sodium metabisulphite is used as an anti-oxidant. The formulated carbomer gel was very clear, transparent and elegant. Incorporation of gelatin microspheres resulted in finely dispersed particles in the gel system. A loading dose of the free drug was incorporated in the carbomer gel to produce immediate effect while drug-loaded microspheres are added to provide sustaining dose.
Volume-surface mean diameter microspheres is important in drug delivery because it is inversely related to the specific surface area [13] and hence the release rate. Larger the diameter, slower the drug release and vice versa.
Drug-loaded microspheres were larger in size than the unloaded ones. Diclofenac sodium loaded microspheres were larger than metronidazole-loaded microspheres. Crosslinking of gelatin with glutaraldehyde mormally would shrink the polymeric network [14] , resulting in the reduction of particle size. The greater the degree of cross-linking the smaller the diameter microspheres. Perhaps, there was less cross-linking with diclofenac sodium than with metronidazole during microsphere formation. Particle diameter is an important factor influencing drug release and retention in target tissue.
The size of periodontal pockets varies between 1 to 4 mm depending on the disease condition [4] . Particle sizes between 20 to 120 m have been suggested to be suitable for periodontal applications [15] . Thus the sizes of the microspheres were within the desired range.
Previous FT-IR studies conducted in our laboratory indicate that there was no interaction between gelatin and metronidazole [12] or diclofenac sodium [10, 14] . The smaller peaks in the DSC of the physical mixture of unloaded microspheres and metronidazole/diclofenac sodium compare with those of the individual drugs is due to low quantities of the drugs in the physical mixture. The completely absence of crystalline drug peaks in the microsphere formulation, like in the FT-IR spectra, indicates the transformation of the drugs from crystalline to amorphous state.
It is difficult to mimic the physiological environment in periodontal pockets. The drug release study was performed in both static and dynamic environments. Drug release from gelatin microspheres based on the static model was designed to mimic the static state inside the carbomer gel. The egg membrane pouch was used as a model for periodontal pocket in order to determine the diffusion of drug across biological membrane. Both the microspheres and gel formulations sustained the drug release more than 4 h, indicating the capacity of the formulated gel and microspheres to release the drugs for a prolonged period. The burst drug release produced by both the microspheres and the gel formulation would be beneficial in getting achieving rapid onset of action. Burst release was approx. 10 % higher for gel than for microspheres. Thus, the burst and sustained release pattern of the gel formulation will be useful in treating inflammation and infection locally in periodontal cavities. Formulation of diclofenac sodium showed faster release than the metronidazole. Diclofenac sodium formulation showed faster release than metronidazole formulation due probably to the higher solubility and lower degree of cross-linking of the former at pH 7.2.
Higher regression coefficient was obtained with Higuchi than with first order and zero order. These findings indicate that drug release from the microspheres was diffusioncontrolled. With time, drug release rate fell as the drug molecule had to diffuse through the longer pathway in cross-linked gelatin matrix. The n value obtained from the release data of microspheres suggests that drug mechanism was pseudo-Fickian diffusion.
CONCLUSION
The formulated microspheres showed good drug-loading. The gel formulation, which consisted of drug-loaded gelatin microspheres, showed sustained release of diclofenac sodium and metronidazole hydrochloride for ≥ 4 h, thus indicating their suitability for the sustained delivery of the drugs for the treatment of inflammation and infections in periodontal pockets. However, further studies, including clinical tests are required to confirm the gel's therapeutic efficacy.
